Literature DB >> 12689927

Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.

Michelle M Le Beau1, Elizabeth M Davis, Bhumi Patel, Vernon T Phan, Jastinder Sohal, Scott C Kogan.   

Abstract

Acute promyelocytic leukemia (APL) is characterized by the PML-RARA fusion gene. To identify genetic changes that cooperate with PML-RARA, we performed spectral karyotyping analysis of myeloid leukemias from transgenic PML-RARA mice and from mice coexpressing PML-RARA and BCL2, IL3, activated IL3R, or activated FLT3. A cooperating mutation that enhanced survival (BCL2) was not sufficient to complete transformation and was associated with multiple numeric abnormalities, whereas cooperating mutations that deregulated growth and enhanced survival were associated with normal karyotypes (IL3) or simple karyotypic changes (IL3R, FLT3). Recurring abnormalities included trisomy 15 (49%), trisomy 8 (46%), and -X/-Y (54%). The most common secondary abnormality in human APL is +8 or partial trisomy of 8q24, syntenic to mouse 15. These murine leukemias have a defined spectrum of changes that recapitulates, in part, the cytogenetic abnormalities found in human APL. Our results demonstrate that different cooperating events may generate leukemia via different pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689927     DOI: 10.1182/blood-2003-01-0155

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.

Authors:  Geoffrey L Uy; Andrew A Lane; John S Welch; Nicole R Grieselhuber; Jacqueline E Payton; Timothy J Ley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

2.  Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.

Authors:  Matthew J Walter; John S Park; Rhonda E Ries; Steven K M Lau; Michael McLellan; Sara Jaeger; Richard K Wilson; Elaine R Mardis; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

3.  FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.

Authors:  Matthew A Kutny; Barry K Moser; Kristina Laumann; James H Feusner; Alan Gamis; John Gregory; Richard A Larson; Bayard L Powell; Wendy Stock; Cheryl L Willman; William G Woods; Soheil Meshinchi
Journal:  Pediatr Blood Cancer       Date:  2012-02-29       Impact factor: 3.167

4.  PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway.

Authors:  Ying Huang; Jia-Kai Hou; Ting-Ting Chen; Xu-Yun Zhao; Zhao-Wen Yan; Jing Zhang; Jie Yang; Scott C Kogan; Guo-Qiang Chen
Journal:  Autophagy       Date:  2011-10-01       Impact factor: 16.016

5.  Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.

Authors:  Robert E Gallagher; Barry K Moser; Janis Racevskis; Xavier Poiré; Clara D Bloomfield; Andrew J Carroll; Rhett P Ketterling; Diane Roulston; Esther Schachter-Tokarz; Da-Cheng Zhou; I-Ming L Chen; Richard Harvey; Greg Koval; Dorie A Sher; James H Feusner; Martin S Tallman; Richard A Larson; Bayard L Powell; Frederick R Appelbaum; Elisabeth Paietta; Cheryl L Willman; Wendy Stock
Journal:  Blood       Date:  2012-06-25       Impact factor: 22.113

6.  Down-regulating the expression of IL-3Rβ interfered with the proliferation, not differentiation in NB4 cells.

Authors:  Xin Li; Yong Wu; Yuanzhong Chen
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

7.  PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice.

Authors:  Nader Omidvar; Mei Lin Maunakea; Letetia Jones; Sabina Sevcikova; Bin Yin; Karen L Himmel; Thelma R Tennant; Michelle M Le Beau; David A Largaespada; Scott C Kogan
Journal:  Haematologica       Date:  2012-11-09       Impact factor: 9.941

8.  Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.

Authors:  Iris T Chan; Jeffery L Kutok; Ifor R Williams; Sarah Cohen; Sandra Moore; Hirokazu Shigematsu; Timothy J Ley; Koichi Akashi; Michelle M Le Beau; D Gary Gilliland
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

9.  Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.

Authors:  Matthew J Walter; John S Park; Steven K M Lau; Xia Li; Andrew A Lane; Rakesh Nagarajan; William D Shannon; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.

Authors:  Xavier Poiré; Barry K Moser; Robert E Gallagher; Kristina Laumann; Clara D Bloomfield; Bayard L Powell; Gregory Koval; Kabir Gulati; Nicholas Holowka; Richard A Larson; Martin S Tallman; Frederick R Appelbaum; Dorie Sher; Cheryl Willman; Elisabeth Paietta; Wendy Stock
Journal:  Leuk Lymphoma       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.